Compare effect of acarbose versus glibenclamide on mean amplitude of glycemic excursion and oxidative stress in patients with type 2 DM [diabetes mellitus] failed to metformin monotherapy
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Acarbose (Primary) ; Glibenclamide (Primary) ; Metformin
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 09 Nov 2011 Results published in the Clinical Therapeutics.
- 01 Oct 2011 Preliminary results published in the Journal of Diabetes and its Complications.
- 18 May 2010 Actual end date (Jan 2009) added as reported by ClinicalTrials.gov.